Brief: Lisata Therapeutics Reports First Quarter 2023 Financial Results And Provides Business Update
09/05/2023 22:59
Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* LISATA THERAPEUTICS INC - AS OF MARCH 31, 2023, CO HAD
CASH,
CASH EQUIVALENTS AND MARKETABLE SECURITIES OF APPROXIMATELY
$61.1 MILLION
* LISATA-CONFIDENT PROJECTED CAPITAL WILL FUND OPERATIONS
INTO Q1
OF 2026 ENCOMPASSING ANTICIPATED DATA MILESTONES FROM
ONGOING,PLANNED CLINICAL TRIALS
* LISATA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.77
Source text for Eikon: ID:nGNX1kkR23
Further company coverage: LSTA.O
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal